APPLAUSE-IgAN

BASEL, July 17, 2026 Novartis announced that the U.S. Food and Drug Administration (FDA) has granted traditional approval for...

BASEL, Oct. 16, 2025 — Novartis announced positive final Phase III results from its APPLAUSE-IgAN trial, confirming that Fabhalta®...